SUSQUEHANNA INTERNATIONAL GROUP, LLP - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,211,723
+48.7%
614,850
+125.0%
0.00%
Q2 2023$2,833,188
-38.0%
273,210
-51.6%
0.00%
-100.0%
Q1 2023$4,570,656
+809.7%
564,976
+1671.1%
0.00%
Q4 2022$502,425
-22.8%
31,900
-22.8%
0.00%
Q3 2022$651,000
+75.9%
41,336
+56.0%
0.00%
Q2 2022$370,000
-46.4%
26,500
-33.8%
0.00%
Q1 2022$690,000
+0.3%
40,000
-15.6%
0.00%
Q4 2021$688,000
-2.3%
47,382
+21.1%
0.00%
Q3 2021$704,000
-72.6%
39,117
-73.3%
0.00%
Q2 2021$2,572,000
-82.2%
146,464
-74.4%
0.00%
-100.0%
Q1 2021$14,435,000
+818.3%
572,835
+135.6%
0.00%
Q4 2020$1,572,000
+4971.0%
243,098
+1942.8%
0.00%
Q3 2020$31,000
-46.6%
11,900
-61.2%
0.00%
Q4 2019$58,000
+38.1%
30,642
-21.0%
0.00%
Q3 2019$42,000
-94.5%
38,785
-88.8%
0.00%
Q2 2019$761,000
+77.0%
347,475
+384.8%
0.00%
Q1 2019$430,000
-66.3%
71,670
+12.1%
0.00%
Q2 2018$1,276,000
+168.1%
63,932
+135.1%
0.00%
Q1 2018$476,000
-85.5%
27,198
-79.6%
0.00%
-100.0%
Q4 2017$3,291,000
+358.4%
133,494
+380.2%
0.00%
Q3 2017$718,000
-28.8%
27,800
-17.7%
0.00%
-100.0%
Q1 2017$1,008,00033,7930.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 441,000$833,0002.78%
MFN Partners Management, LP 4,000,000$7,560,0001.56%
Endurant Capital Management LP 2,055,069$3,884,0001.22%
Broadfin Capital, LLC 1,888,039$3,568,0000.48%
Aisling Capital Management LP 634,455$1,199,0000.46%
EcoR1 Capital, LLC 2,087,312$3,945,0000.36%
Sofinnova Investments, Inc. 1,911,573$3,613,0000.26%
Alambic Investment Management, L.P. 115,036$217,0000.18%
Parkman Healthcare Partners LLC 225,000$425,0000.12%
Rock Springs Capital Management LP 1,600,000$3,024,0000.10%
View complete list of ACLARIS THERAPEUTICS INC shareholders